Who gets left out when cancer patients are asked to donate tissue for research?

Imagine you're a patient in a major cancer trial, already facing a tough diagnosis. Then you're asked to do something extra for science: donate tissue samples for future research. For many, it feels like a chance to help others. But a new look at two large lung cancer trials shows that not everyone says 'yes' at the same rate. The analysis found that 89% of patients agreed to donate for at least one biospecimen study. However, women, patients who weren't non-Hispanic white, and those treated at community sites or smaller academic centers were significantly less likely to participate. This was true even for studies that would require future donations, where 85% agreed overall. The researchers used statistical models to account for other factors, and the gap remained clear. It's important to remember this is an observational analysis—it shows a strong pattern of association, but it can't prove exactly why these differences exist. The worry is that if this pattern holds true across research, the biological samples that scientists use to develop new tests and treatments could end up missing the full diversity of the people who need them most.